Blair William & Co. IL Sells 39,704 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC)

Blair William & Co. IL decreased its holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 6.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 604,737 shares of the company’s stock after selling 39,704 shares during the period. Blair William & Co. IL owned 1.93% of iRhythm Technologies worth $54,529,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Barclays PLC raised its holdings in iRhythm Technologies by 34.3% during the 3rd quarter. Barclays PLC now owns 209,247 shares of the company’s stock valued at $15,534,000 after acquiring an additional 53,498 shares during the period. FMR LLC lifted its holdings in iRhythm Technologies by 7.0% during the 3rd quarter. FMR LLC now owns 388,074 shares of the company’s stock worth $28,811,000 after purchasing an additional 25,385 shares in the last quarter. Wellington Management Group LLP boosted its stake in iRhythm Technologies by 6.2% in the 3rd quarter. Wellington Management Group LLP now owns 213,949 shares of the company’s stock worth $15,884,000 after purchasing an additional 12,478 shares during the period. Verition Fund Management LLC bought a new stake in shares of iRhythm Technologies during the third quarter valued at about $900,000. Finally, Stephens Investment Management Group LLC lifted its holdings in shares of iRhythm Technologies by 25.6% in the fourth quarter. Stephens Investment Management Group LLC now owns 502,925 shares of the company’s stock worth $45,349,000 after buying an additional 102,600 shares in the last quarter.

iRhythm Technologies Trading Up 1.1 %

Shares of IRTC opened at $106.11 on Friday. The company has a debt-to-equity ratio of 9.00, a quick ratio of 6.12 and a current ratio of 6.27. iRhythm Technologies, Inc. has a fifty-two week low of $55.92 and a fifty-two week high of $128.52. The firm has a 50 day moving average price of $108.16 and a 200-day moving average price of $89.69. The firm has a market cap of $3.33 billion, a price-to-earnings ratio of -29.15 and a beta of 1.36.

iRhythm Technologies (NASDAQ:IRTC) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.30. iRhythm Technologies had a negative net margin of 19.14% and a negative return on equity of 118.83%. The business had revenue of $164.33 million during the quarter, compared to analyst estimates of $158.30 million. As a group, equities research analysts forecast that iRhythm Technologies, Inc. will post -1.98 earnings per share for the current year.

Analysts Set New Price Targets

IRTC has been the topic of a number of analyst reports. Truist Financial upped their target price on shares of iRhythm Technologies from $111.00 to $145.00 and gave the stock a “buy” rating in a report on Friday, February 21st. Wells Fargo & Company upped their price target on shares of iRhythm Technologies from $86.00 to $104.00 and gave the stock an “equal weight” rating in a report on Friday, February 21st. Canaccord Genuity Group lifted their price objective on iRhythm Technologies from $125.00 to $152.00 and gave the company a “buy” rating in a research note on Monday, December 9th. Oppenheimer upped their target price on iRhythm Technologies from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 8th. Finally, The Goldman Sachs Group lifted their price target on iRhythm Technologies from $91.00 to $124.00 and gave the company a “neutral” rating in a research report on Monday, February 24th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, iRhythm Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $119.73.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.